278 related articles for article (PubMed ID: 30337054)
21. Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
Pujol I; Capilla J; Fernández-Torres B; Ortoneda M; Guarro J
J Clin Microbiol; 2002 Jul; 40(7):2618-21. PubMed ID: 12089289
[TBL] [Abstract][Full Text] [Related]
22. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
[TBL] [Abstract][Full Text] [Related]
23. Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Badiee P; Shokohi T; Hashemi J; Mohammadi R; Najafzadeh MJ; Amin Shahidi M; Ghasemi F; Jafarian H
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):15. PubMed ID: 36805670
[TBL] [Abstract][Full Text] [Related]
24. In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients.
Kano R; Hiruma J; Yokota M; Noguchi H; Hase M; Kamata H; Harada K; Hiruma M
Jpn J Infect Dis; 2020 May; 73(3):250-252. PubMed ID: 31875604
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.
Baghi N; Shokohi T; Badali H; Makimura K; Rezaei-Matehkolaei A; Abdollahi M; Didehdar M; Haghani I; Abastabar M
Med Mycol; 2016 Oct; 54(7):757-63. PubMed ID: 27118804
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes.
Singh J; Zaman M; Gupta AK
Med Mycol; 2007 Nov; 45(7):595-602. PubMed ID: 17885958
[TBL] [Abstract][Full Text] [Related]
27. Synergistic activity of the combination of falcarindiol and itraconazole
Kan S; Tan J; Cai Q; An L; Gao Z; Yang H; Liu S; Na R; Yang L
Front Cell Infect Microbiol; 2023; 13():1128000. PubMed ID: 37207188
[TBL] [Abstract][Full Text] [Related]
28. In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China.
Bao YQ; Wan Z; Li RY
Mycopathologia; 2013 Feb; 175(1-2):141-5. PubMed ID: 22983900
[TBL] [Abstract][Full Text] [Related]
29. Combinatorial effect of fluconazole, itraconazole, and terbinafine with different culture extracts of Candida parapsilosis and Trichophyton spp. against Trichophyton rubrum.
Lemes TH; Nascentes JAS; Regasini LO; Siqueira JPZ; Maschio-Lima T; Pattini VC; Ribeiro MD; de Almeida BG; de Almeida MTG
Int Microbiol; 2024 Jun; 27(3):899-905. PubMed ID: 37875749
[TBL] [Abstract][Full Text] [Related]
30. In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses.
Koga H; Tsuji Y; Inoue K; Kanai K; Majima T; Kasai T; Uchida K; Yamaguchi H
J Infect Chemother; 2006 Jun; 12(3):163-5. PubMed ID: 16826352
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
[TBL] [Abstract][Full Text] [Related]
32.
Bidaud AL; Schwarz P; Chowdhary A; Dannaoui E
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0144921. PubMed ID: 34633845
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes.
Ghannoum MA; Welshenbaugh A; Imamura Y; Isham N; Mallefet P; Yamaguchi H
Mycoses; 2010 Jul; 53(4):311-3. PubMed ID: 19422522
[TBL] [Abstract][Full Text] [Related]
34. In Vitro Antifungal Activity of Green Synthesized Silver Nanoparticles in Comparison to Conventional Antifungal Drugs Against Trichophyton Interdigitale, Trichophyton Rubrum and Epidermophyton Floccosum.
Mahmoudi S; Vahidi M; Malekabad ES; Izadi A; Khatami M; Dadashi A
Infect Disord Drug Targets; 2021; 21(3):370-374. PubMed ID: 32669080
[TBL] [Abstract][Full Text] [Related]
35. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses.
Clayton YM
Br J Dermatol; 1994 Apr; 130 Suppl 43():7-8. PubMed ID: 8186143
[TBL] [Abstract][Full Text] [Related]
36. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
Shehata AS; Mukherjee PK; Ghannoum MA
J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129
[TBL] [Abstract][Full Text] [Related]
37. Antifungal Susceptibility of Japanese Isolates of Nannizia fulva (Formerly Microsporum fulvum).
Kano R; Oshimo K; Fukutomi T; Kamata H
Med Mycol J; 2019; 60(1):23-25. PubMed ID: 30814467
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of azole derivatives and griseofulvin against planktonic and biofilm growth of clinical isolates of dermatophytes.
Brilhante RSN; Correia EEM; Guedes GMM; de Oliveira JS; Castelo-Branco DSCM; Cordeiro RA; Pinheiro AQ; Chaves LJQ; Pereira Neto WA; Sidrim JJC; Rocha MFG
Mycoses; 2018 Jul; 61(7):449-454. PubMed ID: 29517824
[TBL] [Abstract][Full Text] [Related]
39. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
[TBL] [Abstract][Full Text] [Related]
40. Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes.
Ghannoum MA; Chaturvedi V; Espinel-Ingroff A; Pfaller MA; Rinaldi MG; Lee-Yang W; Warnock DW
J Clin Microbiol; 2004 Jul; 42(7):2977-9. PubMed ID: 15243047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
